enGene Holdings Inc.
ENGN · NASDAQ
7/31/2025 | 4/30/2025 | 1/31/2025 | 10/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $480 |
| % Growth | – | – | -100% | – |
| Cost of Goods Sold | $130 | $106 | $102 | $0 |
| Gross Profit | -$130 | -$106 | -$102 | $240 |
| % Margin | – | – | – | 50% |
| R&D Expenses | $22,575 | $20,209 | $19,974 | $11,273 |
| G&A Expenses | $7,372 | $6,915 | $6,003 | $7,700 |
| SG&A Expenses | $7,372 | $6,915 | $6,003 | $7,700 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $636 | -$1,518 |
| Operating Expenses | $29,947 | $27,124 | $26,613 | $17,455 |
| Operating Income | $29,947 | $27,124 | -$26,613 | -$17,455 |
| % Margin | – | – | – | -3,636.5% |
| Other Income/Exp. Net | -$1,195 | -$1,549 | $2,015 | $2,175 |
| Pre-Tax Income | $28,752 | $25,575 | -$24,598 | -$15,280 |
| Tax Expense | $239 | $240 | $18 | $19 |
| Net Income | -$28,991 | $25,815 | -$24,616 | -$15,299 |
| % Margin | – | – | – | -3,187.3% |
| EPS | -0.57 | 0.51 | -0.48 | -0.34 |
| % Growth | -211.8% | 206.3% | -41.2% | – |
| EPS Diluted | -0.57 | 0.51 | -0.48 | -0.34 |
| Weighted Avg Shares Out | 51,098 | 51,019 | 50,977 | 45,107 |
| Weighted Avg Shares Out Dil | 51,098 | 51,019 | 50,977 | 45,107 |
| Supplemental Information | – | – | – | – |
| Interest Income | $2,233 | $2,488 | $2,730 | $3,024 |
| Interest Expense | $758 | $734 | $752 | $756 |
| Depreciation & Amortization | $130 | $106 | $102 | $83 |
| EBITDA | -$27,864 | -$24,735 | -$23,744 | -$14,441 |
| % Margin | – | – | – | -3,008.5% |